Effects of transfusion of red blood cell concentrates on blood concentration of tacrolimus

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-PAA-013
• By: UCHIDA, Masashi (Graduate School of Pharmaceutical Sciences, Chiba University, Department of Clinical Pharmacy)
• Co-author(s): Masashi Uchida: Division of Pharmacy, Chiba University Hospital, Chiba, Japan;Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
  Shingo Yamazaki: Division of Pharmacy, Chiba University Hospital, Chiba, Japan
  Takaaki Suzuki: Division of Pharmacy, Chiba University Hospital, Chiba, Japan
  Itsuko Ishii: Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan;, Division of Pharmacy, Chiba University Hospital, Chiba, Japan
  
• Abstract:

  Background

  Tacrolimus (TCR) is an immunosuppressive agent used for prevention of graft rejection. Elevation in TCR blood concentration is frequently observed after transfusion of red blood cell concentrates (RCC).

  Methods

  Thirty three patients (age 0 to 65) receiving both TCR (intravenous or oral administration) and RCC transfusion after allogeneic
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login